(Q45420050)

14 December 2017

title

Alzheimer's disease and type 2 diabetes: two diseases, one common link? (English)

1 reference

14 December 2017

0 references

0 references

6

1 reference

14 December 2017

Anne-Kristin Wagner

3

0 references

Peter Riederer

series ordinal

5

object named as

Peter Riederer

1 reference

14 December 2017

1

Jasmin Bartl

1 reference

14 December 2017

author name string

Camelia-Maria Monoranu

series ordinal

2

1 reference

14 December 2017

Jann Kolter

series ordinal

4

1 reference

14 December 2017

publication date

14 February 2012

1 reference

World Journal of Biological Psychiatry

14 December 2017

published in

1 reference

14 December 2017

volume

14

1 reference

14 December 2017

issue

3

1 reference

14 December 2017

page(s)

233-240

1 reference

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Physiological and therapeutic roles of peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Adiposity, type 2 diabetes, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Binding sites of amyloid beta-peptide in cell plasma membrane and implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2011.650204

10.3109/15622975.2011.650204

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference